Sparrow Pharmaceuticals logo
Sparrow Pharmaceuticals logo

Sparrow Pharmaceuticals

sparrowpharma.com
sparrowpharma.com • 51-200 employees • Likely startup • New
51-200 employees • Likely startup • New
Actively hiring
Cardiometabolic Therapeutics
Prescription Drugs
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
2
OrbiMed, USVP
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
OrbiMed fund USVP fund
Similar startupsby what they do, their industry and backers
KaileraFounded 2024 • 51-200 employees • 6 roles
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
2026 Akero Therapeutics, Inc.
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated…
Verdiva Bio
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
LifeMineVenture round $263M · 1 mo ago • Founded 2017 • 501-1000 employees • 1 role
LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages…
Atavistik BioSeries B $120M · 9 mo ago • Founded 2021 • 51-200 employees
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…
DioGenXSeries A $30M · 3 yr ago • Founded 2020 • 11-50 employees
Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment.

Overview

Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess.